Israel Chemicals Limited

13F holders, Q1 2025 (March 31)
1holders
0new positions
0sold out
$5.63avg. 13F price*

At the end of Q1 2025, 1 institutions reported holding Israel Chemicals Limited in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Cigna Investments Inc. ($77K).

Company
Israel Chemicals Limited
Filed as
ICL GROUP LTD ILS1 (Q1 2025)
CUSIP
M5920A109
Latest filing quarter
Q2 2026

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q4 2024 → Q1 2025: 2,761 shares sold, net −2,761 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Cigna Investments Inc. 0.01% Reduce -16.8% 13,682 $77K

"% of holder's portfolio" is ISRAEL CHEMICALS LIMITED's weight in each manager's 13F, not the share of Israel Chemicals Limited the manager owns.